PDB Short entry for 4ZYC HEADER LIGASE 21-MAY-15 4ZYC TITLE DISCOVERY OF DIHYDROISOQUINOLINONE DERIVATIVES AS NOVEL INHIBITORS OF TITLE 2 THE P53-MDM2 INTERACTION WITH A DISTINCT BINDING MODE: HDM2 (MDM2) TITLE 3 COMPLEXED WITH CPD5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE MDM2; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN, P53-BINDING DOMAIN, UNP RESIDUES 17-111; COMPND 5 SYNONYM: DOUBLE MINUTE 2 PROTEIN,HDM2,ONCOPROTEIN MDM2,P53-BINDING COMPND 6 PROTEIN MDM2; COMPND 7 EC: 6.3.2.-; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MDM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PPI WITH P53, INHIBITOR COMPLEX, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR J.KALLEN REVDAT 4 10-JAN-24 4ZYC 1 REMARK REVDAT 3 29-NOV-17 4ZYC 1 REMARK REVDAT 2 12-AUG-15 4ZYC 1 JRNL REVDAT 1 22-JUL-15 4ZYC 0 JRNL AUTH F.GESSIER,J.KALLEN,E.JACOBY,P.CHENE,T.STACHYRA-VALAT, JRNL AUTH 2 S.RUETZ,S.JEAY,P.HOLZER,K.MASUYA,P.FURET JRNL TITL DISCOVERY OF DIHYDROISOQUINOLINONE DERIVATIVES AS NOVEL JRNL TITL 2 INHIBITORS OF THE P53-MDM2 INTERACTION WITH A DISTINCT JRNL TITL 3 BINDING MODE. JRNL REF BIOORG.MED.CHEM.LETT. V. 25 3621 2015 JRNL REFN ESSN 1464-3405 JRNL PMID 26141769 JRNL DOI 10.1016/J.BMCL.2015.06.058 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0063 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 20068 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.222 REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1089 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1450 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2140 REMARK 3 BIN FREE R VALUE SET COUNT : 74 REMARK 3 BIN FREE R VALUE : 0.2680 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2115 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 119 REMARK 3 SOLVENT ATOMS : 104 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.57000 REMARK 3 B22 (A**2) : 0.37000 REMARK 3 B33 (A**2) : -1.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.77000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.204 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.175 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.110 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.718 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.937 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.921 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2287 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3087 ; 1.057 ; 2.053 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 252 ; 5.620 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 92 ;45.849 ;23.478 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 427 ;15.451 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;17.818 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 334 ; 0.068 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1664 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 4ZYC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-MAY-15. REMARK 100 THE DEPOSITION ID IS D_1000210107. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-NOV-08 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97940 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21169 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 31.0700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.30 REMARK 200 R MERGE FOR SHELL (I) : 0.25000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.210 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4DIJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 0.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 0.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: RESERVOIR: 2.2M AMMONIUM SULPHATE, REMARK 280 0.2M KNA TARTRATE, PROTEIN: 10MG/ML HDM2 IN 50MM TRIS PH 8.0, REMARK 280 200MM NACL, 1MM TCEP, 10% GLYCEROL, DROP: 0.2UL RESERVOIR + REMARK 280 0.2UL PROTEIN, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 24.89000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 16 REMARK 465 SER A 17 REMARK 465 GLN A 18 REMARK 465 ILE A 19 REMARK 465 PRO A 20 REMARK 465 ALA A 21 REMARK 465 SER A 22 REMARK 465 GLU A 23 REMARK 465 GLN A 24 REMARK 465 VAL A 109 REMARK 465 VAL A 110 REMARK 465 ASN A 111 REMARK 465 GLY B 16 REMARK 465 SER B 17 REMARK 465 GLN B 18 REMARK 465 ILE B 19 REMARK 465 PRO B 20 REMARK 465 ALA B 21 REMARK 465 SER B 22 REMARK 465 GLU B 23 REMARK 465 GLN B 24 REMARK 465 GLU B 25 REMARK 465 GLY C 16 REMARK 465 SER C 17 REMARK 465 GLN C 18 REMARK 465 ILE C 19 REMARK 465 PRO C 20 REMARK 465 ALA C 21 REMARK 465 SER C 22 REMARK 465 GLU C 23 REMARK 465 GLN C 24 REMARK 465 GLU C 25 REMARK 465 ASN C 111 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 73 -30.36 68.91 REMARK 500 HIS B 73 -33.69 73.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4SS A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4SS A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4SS B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 C 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4DIJ RELATED DB: PDB REMARK 900 RELATED ID: 4OQ3 RELATED DB: PDB DBREF 4ZYC A 17 111 UNP Q00987 MDM2_HUMAN 17 111 DBREF 4ZYC B 17 111 UNP Q00987 MDM2_HUMAN 17 111 DBREF 4ZYC C 17 111 UNP Q00987 MDM2_HUMAN 17 111 SEQADV 4ZYC GLY A 16 UNP Q00987 EXPRESSION TAG SEQADV 4ZYC GLU A 33 UNP Q00987 LEU 33 ENGINEERED MUTATION SEQADV 4ZYC GLY B 16 UNP Q00987 EXPRESSION TAG SEQADV 4ZYC GLU B 33 UNP Q00987 LEU 33 ENGINEERED MUTATION SEQADV 4ZYC GLY C 16 UNP Q00987 EXPRESSION TAG SEQADV 4ZYC GLU C 33 UNP Q00987 LEU 33 ENGINEERED MUTATION SEQRES 1 A 96 GLY SER GLN ILE PRO ALA SER GLU GLN GLU THR LEU VAL SEQRES 2 A 96 ARG PRO LYS PRO GLU LEU LEU LYS LEU LEU LYS SER VAL SEQRES 3 A 96 GLY ALA GLN LYS ASP THR TYR THR MET LYS GLU VAL LEU SEQRES 4 A 96 PHE TYR LEU GLY GLN TYR ILE MET THR LYS ARG LEU TYR SEQRES 5 A 96 ASP GLU LYS GLN GLN HIS ILE VAL TYR CYS SER ASN ASP SEQRES 6 A 96 LEU LEU GLY ASP LEU PHE GLY VAL PRO SER PHE SER VAL SEQRES 7 A 96 LYS GLU HIS ARG LYS ILE TYR THR MET ILE TYR ARG ASN SEQRES 8 A 96 LEU VAL VAL VAL ASN SEQRES 1 B 96 GLY SER GLN ILE PRO ALA SER GLU GLN GLU THR LEU VAL SEQRES 2 B 96 ARG PRO LYS PRO GLU LEU LEU LYS LEU LEU LYS SER VAL SEQRES 3 B 96 GLY ALA GLN LYS ASP THR TYR THR MET LYS GLU VAL LEU SEQRES 4 B 96 PHE TYR LEU GLY GLN TYR ILE MET THR LYS ARG LEU TYR SEQRES 5 B 96 ASP GLU LYS GLN GLN HIS ILE VAL TYR CYS SER ASN ASP SEQRES 6 B 96 LEU LEU GLY ASP LEU PHE GLY VAL PRO SER PHE SER VAL SEQRES 7 B 96 LYS GLU HIS ARG LYS ILE TYR THR MET ILE TYR ARG ASN SEQRES 8 B 96 LEU VAL VAL VAL ASN SEQRES 1 C 96 GLY SER GLN ILE PRO ALA SER GLU GLN GLU THR LEU VAL SEQRES 2 C 96 ARG PRO LYS PRO GLU LEU LEU LYS LEU LEU LYS SER VAL SEQRES 3 C 96 GLY ALA GLN LYS ASP THR TYR THR MET LYS GLU VAL LEU SEQRES 4 C 96 PHE TYR LEU GLY GLN TYR ILE MET THR LYS ARG LEU TYR SEQRES 5 C 96 ASP GLU LYS GLN GLN HIS ILE VAL TYR CYS SER ASN ASP SEQRES 6 C 96 LEU LEU GLY ASP LEU PHE GLY VAL PRO SER PHE SER VAL SEQRES 7 C 96 LYS GLU HIS ARG LYS ILE TYR THR MET ILE TYR ARG ASN SEQRES 8 C 96 LEU VAL VAL VAL ASN HET 4SS A 201 38 HET 4SS A 202 38 HET 4SS B 201 38 HET SO4 C 201 5 HETNAM 4SS (S)-2-(2-((2H-TETRAZOL-5-YL)METHOXY)-4-METHYLPHENYL)-1- HETNAM 2 4SS (4-CHLOROPHENYL)-6,7-DIETHOXY-1,2-DIHYDROISOQUINOLIN- HETNAM 3 4SS 3(4H)-ONE HETNAM SO4 SULFATE ION FORMUL 4 4SS 3(C28 H28 CL N5 O4) FORMUL 7 SO4 O4 S 2- FORMUL 8 HOH *104(H2 O) HELIX 1 AA1 LYS A 31 VAL A 41 1 11 HELIX 2 AA2 MET A 50 LYS A 64 1 15 HELIX 3 AA3 ASP A 80 GLY A 87 1 8 HELIX 4 AA4 GLU A 95 ARG A 105 1 11 HELIX 5 AA5 LYS B 31 VAL B 41 1 11 HELIX 6 AA6 MET B 50 LYS B 64 1 15 HELIX 7 AA7 ASP B 80 GLY B 87 1 8 HELIX 8 AA8 GLU B 95 ARG B 105 1 11 HELIX 9 AA9 LYS C 31 VAL C 41 1 11 HELIX 10 AB1 MET C 50 LYS C 64 1 15 HELIX 11 AB2 ASP C 80 GLY C 87 1 8 HELIX 12 AB3 GLU C 95 ARG C 105 1 11 SHEET 1 AA1 2 LEU A 27 VAL A 28 0 SHEET 2 AA1 2 TYR A 48 THR A 49 -1 O TYR A 48 N VAL A 28 SHEET 1 AA2 2 ILE A 74 TYR A 76 0 SHEET 2 AA2 2 SER A 90 SER A 92 -1 O PHE A 91 N VAL A 75 SHEET 1 AA3 3 TYR B 48 THR B 49 0 SHEET 2 AA3 3 LEU B 27 PRO B 30 -1 N VAL B 28 O TYR B 48 SHEET 3 AA3 3 LEU B 107 VAL B 109 -1 O VAL B 108 N ARG B 29 SHEET 1 AA4 2 ILE B 74 TYR B 76 0 SHEET 2 AA4 2 SER B 90 SER B 92 -1 O PHE B 91 N VAL B 75 SHEET 1 AA5 3 TYR C 48 THR C 49 0 SHEET 2 AA5 3 LEU C 27 PRO C 30 -1 N VAL C 28 O TYR C 48 SHEET 3 AA5 3 LEU C 107 VAL C 109 -1 O VAL C 108 N ARG C 29 SHEET 1 AA6 2 ILE C 74 TYR C 76 0 SHEET 2 AA6 2 SER C 90 SER C 92 -1 O PHE C 91 N VAL C 75 SITE 1 AC1 11 LEU A 54 PHE A 55 LEU A 57 GLY A 58 SITE 2 AC1 11 PHE A 86 VAL A 93 HIS A 96 ILE A 99 SITE 3 AC1 11 PHE B 55 4SS B 201 HOH B 306 SITE 1 AC2 13 GLU A 95 HIS A 96 ARG A 97 LYS A 98 SITE 2 AC2 13 THR A 101 HOH A 312 HOH A 334 LEU C 54 SITE 3 AC2 13 GLY C 58 ILE C 61 PHE C 86 HIS C 96 SITE 4 AC2 13 HOH C 303 SITE 1 AC3 12 PHE A 55 4SS A 201 LYS B 51 LEU B 54 SITE 2 AC3 12 PHE B 55 LEU B 57 GLY B 58 PHE B 86 SITE 3 AC3 12 VAL B 93 HIS B 96 ILE B 99 HOH B 306 SITE 1 AC4 3 LYS C 45 ASP C 46 THR C 47 CRYST1 39.020 49.780 75.287 90.00 92.77 90.00 P 1 21 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025628 0.000000 0.001238 0.00000 SCALE2 0.000000 0.020088 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013298 0.00000